Posts by: Joana Fernandes, PhD

Joana Fernandes, PhD

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

June 29, 2017June 29, 2017

Use of Glucocorticoids May Increase Risk of Bone Fracture, Study Finds

Patients with sarcoidosis who are exposed to glucocorticoids have an increased risk of developing osteoporosis and experiencing bone fractures, according to the results of a new study. However, people ... Read more

June 27, 2017June 27, 2017

Sarcoidosis May Affect Esophagus, Causing Difficulty in Swallowing

Sarcoidosis may cause anomalies in the esophagus and subsequently lead to difficulties in swallowing, according to a new case report. The physicians who conducted the study say involvement of ... Read more

June 19, 2017June 23, 2017

ATS Foundation, Mallinckrodt Pharmaceuticals Offer $80,000 Sarcoidosis Research Grant

Researchers working in sarcoidosis may submit project proposals to the American Thoracic Society (ATS) Foundation/Mallinckrodt Pharmaceuticals Research Fellowship in Sarcoidosis, which will award one $80,000 grant ($40,000 a year ... Read more

May 12, 2017May 12, 2017

Airborne Pollutants May Trigger Sarcoidosis, Study Suggests

The prevalence of sarcoidosis may be associated with the presence of high levels of certain chemical elements in the environment, a new study suggests. More studies are warranted to ... Read more

May 10, 2017May 10, 2017

Cibinetide Seems to Regenerate Nerve Fibers, Improve Pain in Sarcoidosis Patients

Treatment with cibinetide (ARA 290) was shown to promote significant corneal nerve and improve pain and functional capacity in a clinical trial with sarcoidosis patients. The trial was conducted ... Read more

May 5, 2017May 5, 2017

Sarcoidosis Patients, Especially Women, Have Increased Risk of Hospitalization

Sarcoidosis patients are more susceptible to hospitalization than the general population, especially female patients, according to results of a new study. More studies are warranted to understand the reasons why ... Read more

April 21, 2017April 21, 2017

Treatment with RCI May Protect Against Prednisone-Induced Lung Damage

Treatment with repository corticotropin (RCI), such as Acthar Gel, may protect the lungs from prednisone-induced damage and improve the outcome in patients with symptomatic pulmonary sarcoidosis, according to results of ... Read more

March 27, 2017March 27, 2017

Certain Sarcoidosis Patients May Be at Risk of Blood Cancer, Study Says

Most patients with sarcoidosis have a similar risk of cancer compared to the general population, but some patients with more a more advanced form of the disease may have twice ... Read more

March 8, 2017March 8, 2017

Infliximab Reported as Effective Therapy for Neurosarcoidosis, But Patients Often Relapse

Infliximab effectively treats neurosarcoidosis, but patients may see their disease return (relapse) over time, according to results of a new study. The study, “Long-Term Outcomes Of Refractory Neurosarcoidosis Treated ... Read more

February 22, 2017February 22, 2017

Minocycline Clears Up Three Sarcoidosis Cases Stemming from Injections, Reseachers Report

Three patients developed subcutaneous sarcoidosis in their arm after receiving an injection, but symptoms disappeared after treatment with minocycline, a broad-spectrum antibiotic, according to a research report. James Abbott ... Read more